Mechanism of action of quetiapine is via modulation of dopamine at the D2 receptor

被引:0
|
作者
Goldstein, J [1 ]
机构
[1] AstraZeneca Pharmaceut LP, Wilmington, DE USA
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:168 / 168
页数:1
相关论文
共 50 条
  • [1] Mechanism of action of quetiapine: modulation of dopamine at the D2 receptor
    Goldstein, JM
    [J]. EUROPEAN PSYCHIATRY, 2004, 19 : 179S - 179S
  • [2] Mechanism of action of quetiapine: A modulator of dopamine at the D2 receptor
    Goldstein, JM
    [J]. BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 204S - 205S
  • [3] Mechanism of action of quetiapine: A modulator of dopamine at the D2 receptor
    Goldstein, JM
    [J]. SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 311 - 311
  • [4] Dopamine D2 receptor SPECT in schizophrenic patients treated by quetiapine
    Pavics, L
    Szekeres, G
    Ambrus, E
    Juhasz, A
    Keri, SZ
    Kovacs, Z
    Galuska, L
    Janka, Z
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1034 - 1034
  • [5] REGULATORY MECHANISM OF D2 DOPAMINE RECEPTOR
    TANAKA, C
    FUJIWARA, H
    KUNO, T
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 1984, 36 : P24 - P24
  • [6] Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas
    Vernaleken, Ingo
    Janouschek, Hildegard
    Raptis, Mardjan
    Hellmann, Sandra
    Veselinovic, Tanja
    Broecheler, Anno
    Boy, Christian
    Cumming, Paul
    Hiemke, Christoph
    Roesch, Frank
    Schaefer, Wolfgang M.
    Gruender, Gerhard
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (07): : 951 - 960
  • [7] Dopamine D2 Receptor Modulation of ET Cell Bursting
    Liu, Shaolin
    Shipley, Michael T.
    [J]. CHEMICAL SENSES, 2008, 33 (08) : S136 - S137
  • [8] Leptin reduces food intake via a dopamine D2 receptor-dependent mechanism
    Billesa, Sonja K.
    Simonds, Stephanie E.
    Cowley, Michael A.
    [J]. MOLECULAR METABOLISM, 2012, 1 (1-2): : 86 - 93
  • [9] Striatal Dopamine D2 Receptor Modulation of Risky Decision Making
    Setlow, Barry
    [J]. NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S80 - S80